Papp K - Search Results

1

Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy.

Embil JM, Papp K, Sibbald G, Tousignant J, Smiell JM, Wong B, Lau CY. Embil JM, et al. Among authors: papp k. Wound Repair Regen. 2000 May-Jun;8(3):162-8. doi: 10.1046/j.1524-475x.2000.00162.x. Wound Repair Regen. 2000. PMID: 10886806 Clinical Trial.

2

The role of Apligraf in the treatment of venous leg ulcers.

Dolynchuk K, Hull P, Guenther L, Sibbald RG, Brassard A, Cooling M, Delorme L, Gulliver W, Bourassa DH, Ho V, Kunimoto B, Overholt T, Papp K, Tousignant J. Dolynchuk K, et al. Among authors: papp k. Ostomy Wound Manage. 1999 Jan;45(1):34-43. Ostomy Wound Manage. 1999. PMID: 10085970 Review.

3

Real-world effectiveness of adalimumab in patients with moderate-to-severe hidradenitis suppurativa: the 1-year SOLACE study.

Gulliver W, Alavi A, Wiseman MC, Gooderham MJ, Rao J, Alam MS, Papp KA, Desjardins O, Jean C. Gulliver W, et al. Among authors: papp ka. J Eur Acad Dermatol Venereol. 2021 Dec;35(12):2431-2439. doi: 10.1111/jdv.17598. Epub 2021 Aug 25. J Eur Acad Dermatol Venereol. 2021. PMID: 34378812 Free PMC article.

4

Efficacy and safety of adalimumab when added to inadequate therapy for the treatment of psoriasis: results of PRIDE, an open-label, multicentre, phase IIIb study.

Papp K, Ho V, Teixeira HD, Guerette B, Chen K, Lynde C. Papp K, et al. J Eur Acad Dermatol Venereol. 2012 Aug;26(8):1007-13. doi: 10.1111/j.1468-3083.2011.04225.x. Epub 2011 Oct 25. J Eur Acad Dermatol Venereol. 2012. PMID: 22023702 Clinical Trial.

5

Long-term outcomes of interruption and retreatment vs. continuous therapy with adalimumab for psoriasis: subanalysis of REVEAL and the open-label extension study.

Papp K, Menter A, Poulin Y, Gu Y, Sasso EH. Papp K, et al. J Eur Acad Dermatol Venereol. 2013 May;27(5):634-42. doi: 10.1111/j.1468-3083.2012.04515.x. Epub 2012 Mar 16. J Eur Acad Dermatol Venereol. 2013. PMID: 22429586 Clinical Trial.

6

Open-label study of etanercept treatment in patients with moderate-to-severe plaque psoriasis who lost a satisfactory response to adalimumab.

Bagel J, Tyring S, Rice KC, Collier DH, Kricorian G, Chung J, Iles J, Stolshek BS, Kaliyaperumal A, Papp KA. Bagel J, et al. Among authors: papp ka. Br J Dermatol. 2017 Aug;177(2):411-418. doi: 10.1111/bjd.15381. Epub 2017 Jul 19. Br J Dermatol. 2017. PMID: 28196270 Clinical Trial.

7

Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up.

Papp KA, Lebwohl MG, Puig L, Ohtsuki M, Beissert S, Zeng J, Rubant S, Sinvhal R, Zhao Y, Soliman AM, Alperovich G, Leonardi C. Papp KA, et al. Br J Dermatol. 2021 Dec;185(6):1135-1145. doi: 10.1111/bjd.20595. Epub 2021 Sep 21. Br J Dermatol. 2021. PMID: 34157132 Free PMC article. Clinical Trial.

8

Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3.

Papp KA, Gordon KB, Langley RG, Lebwohl MG, Gottlieb AB, Rastogi S, Pillai R, Israel RJ. Papp KA, et al. Br J Dermatol. 2018 Aug;179(2):320-328. doi: 10.1111/bjd.16464. Epub 2018 May 23. Br J Dermatol. 2018. PMID: 29488226 Clinical Trial.

9

Cost-effectiveness evaluation of clobetasol propionate shampoo (CPS) maintenance in patients with moderate scalp psoriasis: a Pan-European analysis.

Papp K, Poulin Y, Barber K, Lynde C, Prinz JC, Berg M, Kerrouche N, Rives VP. Papp K, et al. J Eur Acad Dermatol Venereol. 2012 Nov;26(11):1407-14. doi: 10.1111/j.1468-3083.2011.04305.x. Epub 2011 Oct 27. J Eur Acad Dermatol Venereol. 2012. PMID: 22032474

10

A phase 2a randomized, double-blind, placebo-controlled, sequential dose-escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate-to-severe psoriasis.

Papp K, Pariser D, Catlin M, Wierz G, Ball G, Akinlade B, Zeiher B, Krueger JG. Papp K, et al. Br J Dermatol. 2015 Sep;173(3):767-76. doi: 10.1111/bjd.13745. Epub 2015 Jun 19. Br J Dermatol. 2015. PMID: 25704750 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

746 results

Search Page

Filters